D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4201
iShares MSCI India Small-Cap ETF
SMIN
$677M
| $378K | ﹤0.01% |
5,351
-5,992
| -53% | -$399K |
2025 Q1
5 quarters
|
|
4202
Agora
API
$371M
| $377K | ﹤0.01% |
94,386
| – | – |
2022 Q1
17 quarters
|
|
4203
CALL
Stanley Black & Decker
SWK
$14.9B
| $376K | ﹤0.01% |
4,000
-1,400
| -26% | -$110K |
2025 Q1
5 quarters
|
|
4204
M&T Bank
MTB
$32.2B
| $376K | ﹤0.01% |
+1,578
| New | +$345K |
2026 Q2
0 quarters
|
|
4205
Climb Bio
CLYM
$605M
| $376K | ﹤0.01% |
+28,800
| New | +$297K |
2026 Q2
0 quarters
|
|
4206
Forward Industries Inc
FWDI
$533M
| $374K | ﹤0.01% |
+88,735
| New | +$396K |
2026 Q2
0 quarters
|
|
4207
AGCO
AGCO
$7.44B
| $371K | ﹤0.01% |
3,103
-100
| -3% | -$11.6K |
2023 Q2
12 quarters
|
|
4208
Odyssey Therapeutics
ODTX
$917M
| $371K | ﹤0.01% |
+19,848
| New | +$348K |
2026 Q2
0 quarters
|
|
4209
Innovex International
INVX
$1.95B
| $371K | ﹤0.01% |
+14,955
| New | +$406K |
2026 Q2
0 quarters
|
|
4210
Columbia Research Enhanced Core ETF
RECS
$6.19B
| $370K | ﹤0.01% |
8,547
+845
| +11% | +$35.8K |
2026 Q1
1 quarter
|
|
4211
CALL
Factset
FDS
$11.9B
| $368K | ﹤0.01% |
1,600
-1,600
| -50% | -$367K |
2026 Q1
1 quarter
|
|
4212
Oceaneering
OII
$3.64B
| $367K | ﹤0.01% |
+9,049
| New | +$341K |
2026 Q2
0 quarters
|
|
4213
CALL
Incyte
INCY
$23.7B
| $363K | ﹤0.01% |
3,200
| – | – |
2025 Q4
2 quarters
|
|
4214
CALL
The Mosaic Company
MOS
$5.49B
| $362K | ﹤0.01% |
+17,100
| New | +$395K |
2026 Q2
0 quarters
|
|
4215
AFC Gamma
AFCG
$68.3M
| $361K | ﹤0.01% |
116,471
+18,847
| +19% | +$59.2K |
2024 Q1
9 quarters
|
|
4216
CALL
Eagle Materials
EXP
$5.48B
| $360K | ﹤0.01% |
1,600
| – | – |
2026 Q1
1 quarter
|
|
4217
CALL
Methanex
MEOH
$4.7B
| $360K | ﹤0.01% |
7,800
| – | – |
2025 Q2
4 quarters
|
|
4218
Maze Therapeutics
MAZE
$1.77B
| $359K | ﹤0.01% |
12,019
-33,617
| -74% | -$881K |
2025 Q4
2 quarters
|
|
4219
Huntsman Corp
HUN
$1.53B
| $359K | ﹤0.01% |
33,759
-339,749
| -91% | -$4.68M |
2015 Q2
44 quarters
|
|
4220
PUT
Navitas Semiconductor
NVTS
$2.23B
| $358K | ﹤0.01% |
+20,000
| New | +$382K |
2026 Q2
0 quarters
|
|
4221
CALL
H&R Block
HRB
$6.13B
| $358K | ﹤0.01% |
9,400
-8,600
| -48% | -$300K |
2025 Q4
2 quarters
|
|
|
KARD
4222
Kardigan Inc
KARD
$1.19B
| $358K | ﹤0.01% |
+15,000
| New | +$347K |
2026 Q2
0 quarters
|
|
4223
UP Fintech Holding
TIGR
$730M
| $357K | ﹤0.01% |
81,146
-344,209
| -81% | -$2.01M |
2023 Q3
11 quarters
|
|
4224
Wendy's
WEN
$1.25B
| $357K | ﹤0.01% |
+43,067
| New | +$308K |
2026 Q2
0 quarters
|
|
4225
AbCellera Biologics
ABCL
$3.68B
| $357K | ﹤0.01% |
+45,431
| New | +$222K |
2026 Q2
0 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.